| Medicare Noridian | Billing and Coding: MolDX: Breast Cancer Index® (BCI) Gene Expression Test (57773) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia (59032) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (59179) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma (59386) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy (59505) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers (59513) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (59521) | 2026-01-12 |
| Carelon Medical Benefits Management | Treatment of Varicose Veins and Superficial Venous Insufficiency 2026-01-10 | 2026-01-10 |
| Aetna | Electroencephalographic (EEG) Video Monitoring | 2026-01-09 |
| Aetna | Strontium Chloride Sr-89 | 2026-01-09 |